RTX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
RTX is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 who wants to act now without waiting for a better entry. The stock has solid defense-related catalysts and constructive technical momentum, but the latest analyst revision trend is mixed-to-negative, insiders are selling aggressively, and there is no proprietary AI Stock Picker or SwingMax buy signal today. My direct view: hold off on a new full-position buy right now; it is acceptable to own if already held, but not the best immediate buy.
RTX is in a mild uptrend with positive momentum: MACD histogram is 1.13 and expanding above zero, which supports bullish continuation. RSI_6 at 60.252 is neutral-to-slightly bullish, not overbought. Moving averages are converging, suggesting the trend is improving but not yet a strong breakout setup. Pre-market price is 178.47, just below the reported current price 178.96, and near pivot 176.099 with resistance at R1 180.213 and R2 182.755. That places the stock close to near-term resistance rather than an obvious discount entry.
Recent contract wins are meaningful: RTX received a $1.02 billion NASAMS fire unit procurement contract, which supports defense revenue visibility. News also highlights ongoing missile production modernization and a $22 million facility investment, both positive for long-term execution. The aerospace/defense backdrop remains supported by higher defense spending and resilient demand. Recent analyst commentary from Morgan Stanley and Citi remains constructive, with Morgan Stanley still calling RTX its Top Pick in Aerospace.
Analyst sentiment has weakened at the margin: Erste Group downgraded RTX to Hold, citing slower sales and earnings growth versus competitors. UBS and Jefferies lowered price targets, showing reduced near-term enthusiasm. Insider activity is a notable negative, with insiders selling and the selling amount up 1363.87% over the last month. There is no recent congress trading data, and hedge funds are neutral with no significant quarter-over-quarter trend. The stock is also trading near resistance, limiting immediate upside from current levels.
No usable latest-quarter financial snapshot was provided because the financial data section returned an error. Based on the analyst commentary, the latest quarter appears operationally decent, with UBS noting a third consecutive quarter of EBIT beats across all segments, strong execution, and solid defense momentum. However, multiple analysts also point to slower growth versus peers and lingering risks, so the broader growth picture appears steady rather than exceptional. Latest quarter season: not explicitly provided in the data, but the analyst notes refer to the recent quarter ahead of Q1 preview and recent earnings updates.
Analyst views are mixed but slightly constructive overall. Recent changes: Erste Group downgraded to Hold, UBS cut its target to $199 and stayed Neutral, Morgan Stanley cut its target to $220 but remained Overweight and Top Pick, Jefferies kept Hold with a lower target, Melius upgraded to Buy, Citi kept Buy while trimming target, Wells Fargo initiated Equal Weight, Erste earlier initiated Buy, and Deutsche Bank kept Buy with a higher target. Wall Street pros: strong defense demand, contract wins, resilient aerospace demand, and a valuation discount argument. Cons: slower growth than peers, some downside concerns for 2027 aftermarket demand, and uneven operational performance versus expectations. Net: the pro case is still there, but conviction has weakened recently.
